Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study - Top-Institutions - MDSpire

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study

  • By

  • Danbee Kang

  • Sang Eun Yoon

  • Dongwook Shin

  • Jin Lee

  • Yun Soo Hong

  • Se Kyung Lee

  • Jeong Eon Lee

  • Yeon Hee Park

  • Jin Seok Ahn

  • Eliseo Guallar

  • Won Seog Kim

  • Jungho Lee

  • Seok Jin Kim

  • Juhee Cho

  • December 14, 2021

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology-Oncology
    • Lymphoma Research
    • Breast Cancer
  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Cancer Epidemiology
    • Breast Cancer
  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology-Oncology
    • Lymphoma Research
    • Breast Cancer
  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology-Oncology
    • Cancer Epidemiology
    • Breast Cancer

Original Source(s)

Related Content